MedVenture Partners

A-Wave is a manufacturing company specializing in medical devices. It develops and markets innovative solutions, including a remote medical treatment system featuring a wristwatch-type wearable device. This device detects cardiac murmurs, reduced activity, and peripheral colds, enabling early symptom detection of heart failure in patients at home.

A-Wave is a manufacturing company specializing in medical devices. It develops and markets innovative solutions, including a remote medical treatment system featuring a wristwatch-type wearable device. This device detects cardiac murmurs, reduced activity, and peripheral colds, enabling early symptom detection of heart failure in patients at home.

SentiAR, Inc. is a digital health company based in St. Louis, Missouri, focused on developing a 3D augmented reality holographic platform aimed at enhancing interventional medical procedures. Incorporated in 2017 and originating from Washington University, SentiAR's technology allows for real-time holographic visualization of a patient's anatomy and catheter positioning during procedures, utilizing data from various imaging modalities such as CT and MRI. This innovative platform is designed to create an interactive and controllable interface for clinicians, thereby improving the accuracy and safety of cardiac arrhythmia treatments. SentiAR's mission is to significantly enhance the experience for both patients and healthcare providers in catheter lab environments. The company is currently working towards obtaining FDA approval for its platform.

Avisi Technologies Inc. is a Philadelphia-based company founded in 2017 that specializes in developing innovative solutions for glaucoma treatment. Its primary product, VisiPlate, is a next-generation, nanotechnology-enabled aqueous shunt designed to prevent blindness caused by glaucoma. Through its advanced technology, Avisi Technologies aims to enhance the effectiveness of glaucoma management and improve patient outcomes.

mediVR, Inc. is a Tokyo-based company focused on developing and manufacturing therapeutic medical devices that leverage virtual reality, three-dimensional tracking, and artificial intelligence technologies to enhance rehabilitation programs. Founded in 2016, the company offers mediVR Kagura, a self-exercise device designed to assess motor function, posture balance, and cognitive skills essential for walking. This innovative platform facilitates various body movement exercises through engaging games and activities, utilizing a base station, virtual reality headset, and handheld controllers. By marketing its device via a network of distributors, mediVR aims to support clinicians and families in accelerating rehabilitation for patients, particularly those recovering from strokes. The company also has an office in Osaka, further extending its reach in the healthcare sector.

CorVista Health, Inc. is an innovative medical technology company specializing in artificial intelligence-based digital health and medical imaging solutions, particularly for coronary artery and pulmonary hypertension diseases. The company has developed a non-invasive cardiac diagnostic platform that allows physicians to assess heart function without the need for radiation, contrast agents, injections, fasting, or exercise. This portable device, which can operate using WiFi or cellular signals, is designed for point-of-care environments such as doctors' offices, satellite clinics, nursing homes, and mobile settings. Founded in 2012 and headquartered in Toronto, Canada, CorVista Health also maintains additional offices in Cary, North Carolina, and Shanghai, China. The firm's approach integrates advanced mathematics, physics, artificial intelligence, and cloud computing to enhance cardiovascular diagnostics.

Alivas Inc. is a medical company focused on developing therapeutic medical devices specifically designed to treat refractory constipation. Founded in 2017, the company is based in Hongo, Tokyo, Japan. Alivas is a collaborative venture between Stanford University and the University of Tokyo, leveraging the Japan Biodesign program to foster innovation in medical device creation. The company's device aims to provide effective treatment solutions for patients suffering from intractable chronic constipation, helping them alleviate their condition and improve their quality of life.

Alivas Inc. is a medical company focused on developing therapeutic medical devices specifically designed to treat refractory constipation. Founded in 2017, the company is based in Hongo, Tokyo, Japan. Alivas is a collaborative venture between Stanford University and the University of Tokyo, leveraging the Japan Biodesign program to foster innovation in medical device creation. The company's device aims to provide effective treatment solutions for patients suffering from intractable chronic constipation, helping them alleviate their condition and improve their quality of life.

SonoMotion Inc. is a medical device company focused on developing non-invasive solutions for kidney stone disease. Founded in 2012 and based in San Mateo, California, the company offers innovative products like Break Wave, which effectively fragments large kidney stones, and Stone Clear, designed to clear the resulting fragments within 15 minutes in an office setting without the need for general anesthesia or X-ray radiation. Additionally, SonoMotion is advancing its technology with a stone repositioning solution currently in clinical trials and a second-generation stone breaking technology in development. The company's mission is to provide caregivers with safe, efficient, and cost-effective treatment options for patients suffering from kidney-related ailments.

PaMeLa Co., Ltd. is a medical device company based in Suita, Japan, founded in 2016. The company focuses on developing innovative technology to measure pain experienced by patients during surgical procedures. By utilizing brain wave analysis, algorithms, and machine learning, PaMeLa aims to create an objective method for quantifying pain. This approach is intended to enhance medical care by providing a scientific basis for pain assessment, thereby improving patient outcomes and treatment strategies.

DO THE SAMURAI, Inc. is a cultural tourism platform based in Tokyo, Japan, founded in 2016. The company operates Hotokami, a website and mobile application that serves as a comprehensive directory for shrines and temples throughout Japan. This platform allows users to easily search for and access information about these historical sites, facilitating travel planning for worshippers and tourists alike. By providing a space for users to post experiences, share visits, and exchange information, DO THE SAMURAI enhances engagement with Japan's rich cultural heritage.

A-Traction Inc. is a Japanese company based in Kashiwa, Chiba, specializing in the development of surgical robots designed for laparoscopic surgery. Founded in 2015, A-Traction aims to enhance surgical precision and safety through innovative medical devices. The company has introduced a concept called ANSUR, wherein the robotic system acts as a collaborative partner to the surgeon during procedures, facilitating smoother and more effective operations. By leveraging advanced technology and a unique approach to robotic assistance, A-Traction seeks to provide high-quality surgical solutions that improve outcomes for patients while ensuring a safer surgical environment.

BMG is a medical company specializing in the development, manufacturing, and sales of biomedical polymer materials and medical devices. The company focuses on creating innovative biomaterial products, including biodegradable and absorbable polymer materials intended for medical applications. BMG's offerings include domestically produced polymers for bioabsorbable sutures, which provide patients with effective alternatives that enhance health outcomes. Through its research and development services, BMG aims to contribute to advancements in the medical field and improve the overall well-being of individuals globally.

A-Traction Inc. is a Japanese company based in Kashiwa, Chiba, specializing in the development of surgical robots designed for laparoscopic surgery. Founded in 2015, A-Traction aims to enhance surgical precision and safety through innovative medical devices. The company has introduced a concept called ANSUR, wherein the robotic system acts as a collaborative partner to the surgeon during procedures, facilitating smoother and more effective operations. By leveraging advanced technology and a unique approach to robotic assistance, A-Traction seeks to provide high-quality surgical solutions that improve outcomes for patients while ensuring a safer surgical environment.

Biomedical Solutions Company, established in 2012 in Tokyo, Japan, specializes in the research and development of neurovascular intervention devices. The company focuses on creating high-quality medical equipment, prioritizing both safety and efficacy, to meet the needs of its clients. Its flagship product is a cerebrovascular thrombus removal device, designed to treat acute cerebral infarction, offering improved visibility and low friction for enhanced patient care.